Compare FOLD & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOLD | MAIN |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.3B |
| IPO Year | 2006 | 2013 |
| Metric | FOLD | MAIN |
|---|---|---|
| Price | $14.36 | $57.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | $27.25 | ★ $61.57 |
| AVG Volume (30 Days) | ★ 4.2M | 645.1K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | ★ 7.50% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ 3.95 |
| Revenue | N/A | N/A |
| Revenue This Year | $20.55 | $5.81 |
| Revenue Next Year | $18.34 | $2.18 |
| P/E Ratio | ★ N/A | $14.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.66 | $47.00 |
| 52 Week High | $14.38 | $67.77 |
| Indicator | FOLD | MAIN |
|---|---|---|
| Relative Strength Index (RSI) | 73.35 | 40.65 |
| Support Level | $14.21 | $55.70 |
| Resistance Level | $14.37 | $58.72 |
| Average True Range (ATR) | 0.04 | 1.82 |
| MACD | -0.04 | -0.25 |
| Stochastic Oscillator | 93.75 | 36.99 |
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.